Skip to content

Author

Marcin Szczepanik

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

ADC – ANTIBODY-DRUG CONJUGATES IN ONCOLOGY

Background: Antibody-drug conjugates (ADC) are a promising novel therapy for oncology patients as it combines tumor- targeted antibodies with cytotoxic molecules resulting in improved therapeutic outcomes. Aim: The aim of this article is a thorough analysis of ADC possibilities in oncology focusing on treatment options...

Jędrzej Kowalski, Dominik Szymczak, Olaf Zołotar et al. · 0 citations
Review Open access Aug 2026

IRRITABLE BOWEL SYNDROME – NEW PERSPECTIVE

Background: IBS is a worldwide chronic gastrointestinal tract disorder. The challenges in treatment include unknown causes, non-specific symptoms, lack of precises testing, diagnosis based on ruling out other ailments. New therapies and probiotics show promise in improving the now available treatments and alleviating s...

Joanna Kulpa, Kornelia Tyczka, Marcin Szczepanik et al. · 0 citations
Open access Aug 2026

CAR-T CELL THERAPY IN ONCOLOGY AND RHEUMATOLOGY

Background: CAR-T cell therapy is a highly personalized form of treatment. it involves modifying T cells extracted from the patients white blood cells during cell collection. Genetic modification of said T cells allows for the extraction of chimeric antigen receptor (CAR), which are later multiplied and infused into th...

Kornelia Tyczka, Marcin Szczepanik, M. Nowakowska et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.